Temasek Holdings

Temasek Holdings, established in 1974 and based in Singapore, is an investment company managing a diversified portfolio valued at approximately S$242 billion. The firm actively invests across various sectors, including telecommunications, media and technology, financial services, transportation, consumer products, real estate, life sciences, and energy. Temasek focuses on long-term investment themes such as transforming economies, growing middle-income populations, deepening comparative advantages, and supporting emerging champions. Its investment strategy encompasses a combination of liquid assets, listed and unlisted equities, and private equity opportunities, with a notable emphasis on mid-stage technology and life sciences investments through its private equity arm, Temasek Capital Management. Furthermore, Temasek aims to be the preferred investor for companies in Singapore and internationally, reflecting its commitment to global investment opportunities.

Pradyumna Agrawal

Director

Soyoun Ahn

Managing Director, Investment (Credit and Hybrid Solutions)

Gary Ang

Managing Director, Macro Strategy

Parimal Aswani

Managing Director, Technology

Ravi Balasubramanian

Managing Director, Portfolio Development, New Energy and Industrials

Siddartha Bhattacharjee

Head of Mobility and Logistics and Managing Director of Portfolio Strategy & Risk Group

Eric Bielke

Director

Wendy Chandra

Managing Director, Technology

Yuliang Chang

Managing Director, Investment (China)

Eu Chua

Managing Director, Institutional Relations and Singapore Market

Ranjit Dandekar

Managing Director, Investment

Promit Ghosh

Managing Director

Reena Kanagasingam

Managing Director, Investment (Public Markets)

Ming Pey Lim

Chief of Staff, Executive Office, Deputy Chief Corporate Officer and Managing Director, Strategy Office

Sheau Ming Lim

Director

Paul Liu

Managing Director, Investment (Financial Services), Portfolio Strategy and Risk Group

Anuj Maheshwari

Head, Agri-Food Managing Director, Investment (Middle East and Africa)

Nicolas Meier

Managing Director, Investment (EMEA) and Director

Jingwen Miao

Managing Director, Investment (China)

Suranjan Mukherjee

Managing Director, Cross Asset Macro Portfolio and Joint Head, Public Market Investment Strategies

Jonathan Popper

Managing Director, Portfolio Development Group

Ryan Rakestraw

Director

Parangam Ray

Managing Director, Organisation and People

Pierce Scranton

Managing Director, Institutional Relations and Deputy Head, North America

Shaun Seow

Managing Director, Singapore Market and Head, Community Stewardship

Rohit Sobti

Managing Director, New Energy and Industrials

Jason Sun

Chief Representative, Beijing and Managing Director, Investment (China)

Belinda Tan

Managing Director, Finance (Financial Management)

Man-Keung Tang

Managing Director, Macro Strategy

Sulian Tay

Operating Partner

Alan Thompson

Operating Partner

Karen Toh

Managing Director, Finance (Treasury)

Damien Vacherot

Director

Benoit Valentin

Senior Managing Director EMEA and Head of Private Equity Fund Investments

Rob Williams

Managing Director, Investment (EMEA)

Ye Xu

Managing Director, Investment (China)

Past deals in Series B

Amogy

Series B in 2023
Amogy is a start-up, located in Brooklyn, New York and is working on a novel carbon-free energy storage system using ammonia as a fuel.

Ionblox

Series B in 2023
Zenlabs has developed proprietary silicon-based formulations that offer higher specific capacity, longer cycle life, and lower cost. Zenlabs' anodes are unique in their high loading level and high active silicon content. In addition, Zenlabs has solved the common problems with silicon based anodes such as poor cycling and swelling. Zenlabs combines these high capacity anodes with high capacity cathode materials in large format pouch cells to achieve energy densities that are much higher than what is commercially available.

Pasqal

Series B in 2023
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.

DotPe

Series B in 2022
DotPe is a technology start-up based in Gurgaon, Haryana, India, founded in 2019 by Anurag Gupta, Gyanesh Sharma, and Shailaz Nag. The company operates a commerce and payments platform designed to enhance customer engagement and streamline the payment experience for offline enterprises. By facilitating digital transformation, DotPe enables businesses to sell directly to consumers, manage their catalogs, and improve overall efficiency. The platform offers various features, including customer management, order management, website management, shipping and logistics, and marketing, helping offline businesses grow and adapt to modern sales strategies.

OnPoint

Series B in 2022
OnPoint is a management consulting firm based in Arlington, Virginia, specializing in delivering secure IT infrastructure and enterprise systems for the U.S. federal government. The company offers a range of technology and management consulting services, including risk management, compliance, strategic integration, security awareness training, and program management. By providing comprehensive solutions, OnPoint helps its clients effectively navigate complex challenges, from marketing and strategic communications to cybersecurity, ensuring that they receive tailored and dynamic support to meet their needs.

Jaguar Microsystems

Series B in 2022
Jaguar Microsystems is a technology company specializing in cloud computing and data processing solutions for data centers. Founded by Dr. Sunny Siu in 2020, the company develops data processing unit (DPU) chips aimed at enhancing the efficiency of data processing for its clients. Jaguar Microsystems offers products that feature accelerated Remote Direct Memory Access (RDMA) and RoCE, specifically designed for data center applications. The company targets domestic cloud service providers, telecommunications, and Internet service providers while also expanding its reach to meet the demands of the global market.

TeraWatt Technology

Series B in 2022
TeraWatt Technology Inc., founded in 2017 and headquartered in Santa Clara, California, with a subsidiary in Tokyo, Japan, specializes in the design and development of lithium-ion rechargeable batteries. The company's focus is on creating batteries that combine high energy density, power density, and safety, catering to various electrified applications. By leveraging advanced engineering and production techniques, TeraWatt Technology aims to provide industrial clients with long-lasting, safe, and reliable power solutions, thereby enhancing the performance of their electrified systems.

Brightseed

Series B in 2022
Brightseed, Inc. is a biotechnology company that specializes in discovering clinically beneficial molecules found in plants through its innovative Forager platform. Founded in 2017 and based in San Francisco, California, the company employs artificial intelligence and machine learning algorithms to screen plant genes, identifying the most effective sources for addressing various health conditions. By uncovering naturally occurring compounds with potential health benefits, Brightseed aims to enhance the quality of life and support chronic disease management. The company’s mission is to strengthen the connection between people and plants, ultimately facilitating a healthier future for individuals and communities.

Waresix

Series B in 2022
Waresix is a logistics platform for freight-forwarding, warehouse, and land transportation. It is a platform that matches unused warehouse space with users in need of such facility, looks to capitalize on the demand for flexible warehousing given the booming e-commerce market in the country. Waresix provides a solution for dynamic warehousing strategy that allows customers, retailer, distributor, and manufacturer to quickly adapt to variable demand. Waresix is headquartered in Jakarta, Indonesia.

Wildtype

Series B in 2022
Wild Type, Inc. is a San Francisco-based company that produces meat, poultry, and seafood through cellular agriculture, eliminating the need for raising or slaughtering animals. Founded in 2016, Wild Type offers a sustainable alternative to traditional food sources, addressing critical issues such as climate change, food security, and public health. By leveraging advanced cellular agriculture technologies, the company aims to redefine how society sources healthy and delicious meat, contributing to a more sustainable food ecosystem.

Amber Group

Series B in 2022
Amber Group is a prominent cryptocurrency financial services provider headquartered in Hong Kong, established in 2017 by finance professionals with backgrounds from major institutions. The company facilitates the buying and selling of cryptocurrency products and offers a range of services including yield enhancement, collateralized lending, decentralized finance, execution services, and electronic market making. Operating globally, Amber Group serves over 200 institutional clients, engaging in significant trading activity across numerous electronic exchanges with an average daily trading volume between $100 million and $200 million. The firm is dedicated to optimizing investment flexibility and maximizing returns for its clients by leveraging advanced technology and quantitative research, thereby enhancing the overall crypto finance experience. In 2019, Amber Group secured $28 million in a Series A funding round, attracting investment from notable players in the cryptocurrency sector.

Soul Machines

Series B in 2022
Soul Machines Limited specializes in creating emotionally responsive avatars that enhance user interactions with artificial intelligence platforms. Founded in 2016 and headquartered in Auckland, New Zealand, the company also operates offices in major cities including San Francisco, New York, London, Tokyo, and Melbourne. Its flagship product, Digital DNA Studio, empowers users to design custom digital personas for various applications, including customer care, marketing, education, and training. By leveraging advanced technology, Soul Machines aims to redefine customer engagement and promote deeper interactivity, ultimately transforming how individuals interact with machines and brands. The company's innovative approach focuses on creating empathetic AI assistants that facilitate meaningful human-machine collaboration, enhancing overall user experiences across multiple sectors, from retail to healthcare.

Waterdrop

Series B in 2022
Waterdrop is a producer of innovative water-based beverages designed to enhance hydration and wellness. The company offers a unique product in the form of small, sugar-free, dissolvable cubes that transform plain water into flavorful drinks. These micro drinks are enriched with vitamins and extracts sourced from high-quality natural ingredients, including fruits and plants. This approach allows consumers to enjoy a refreshing beverage without added sugars while promoting adequate hydration. Waterdrop emphasizes the use of environmentally friendly raw materials, aligning its products with sustainable practices.

H2Pro

Series B in 2022
H2Pro, Ltd. is a company that specializes in innovative water-splitting technology aimed at producing hydrogen fuel. Founded in 2019 and based in Caesarea, Israel, H2Pro has developed a proprietary electrolysis method known as E-TAC (Electrochemical–Thermally-Activated Chemical water splitting). This technology effectively separates the hydrogen and oxygen evolution reactions, offering a super-efficient approach to green hydrogen production.

Wenext

Series B in 2021
Wenext, founded in 2014, specializes in online manufacturing services tailored for makers and small to mid-size enterprises (SMEs). The company has produced over 15 million high-quality parts through its efficient digital production facilities. By offering a flexible supply chain with transparent pricing and 24-hour delivery, Wenext enhances production capacity for its clients. The platform facilitates full self-service production, significantly reducing operational costs and production time, with some orders completed in as little as one day. Wenext is ISO 9001 certified, underscoring its commitment to quality in manufacturing processes.

Commonwealth Fusion

Series B in 2021
Commonwealth Fusion Systems LLC is a research company focused on developing fusion energy as a sustainable solution to combat climate change. Established in 2017 and based in Cambridge, Massachusetts, the company utilizes advanced rare-earth barium copper oxide superconductor technology to create energy through fusion. Commonwealth Fusion Systems combines decades of government-funded fusion research with innovative superconducting magnet technology to expedite the commercialization of fusion energy. The company emerged from the Massachusetts Institute of Technology and collaborates closely with MIT’s Plasma Science and Fusion Center, leveraging extensive research to enhance its development efforts. By designing and building fusion machines, Commonwealth Fusion aims to provide limitless and clean energy, contributing to the global transition toward sustainable energy sources.

RWDC Industries

Series B in 2021
RWDC Industries Ltd specializes in developing and manufacturing biodegradable bioplastics derived from medium chain length polyhydroxyalkanoate (mcl-PHA). Founded in 2015 and based in Singapore, the company produces mcl-PHA through bacterial fermentation of plant-based oils or sugars. RWDC's biopolymers are designed to serve as sustainable alternatives to conventional petroleum-based plastics, offering applications in food and beverage packaging, cutlery, drinking straws, cup lids, and even diapers. One of its notable innovations is a water-based PHA emulsion coating that can replace polyethylene in plastic-lined food packaging. The company emphasizes that its PHA is fully biodegradable in various environments, including soil and marine conditions, which positions it as a responsible choice for reducing plastic waste.

SaladStop!

Series B in 2021
SaladStop! is a pioneer in the healthy food movement in Singapore and aims to serve the best tasting and most nutritious salads, wraps and grain bowls. SaladStop! currently operates 23 outlets in Singapore and Manila and quickly approaching their vision of becoming the world’s leading nutrition, health and wellness company, expanding to Indonesia and Japan later this year.

Arbor Biotechnologies

Series B in 2021
Arbor Biotechnologies operator of a bio-discovery company intended to provide human diagnostic development service. The company's platform employs a diverse set of technologies and techniques including artificial intelligence, genome sequencing, gene synthesis and high-throughput screening, enabling drug developers to accelerate the discovery of proteins for improving human health and sustainability.

FTX

Series B in 2021
FTX Trading LTD is a cryptocurrency derivatives exchange founded in 2017 and based in San Francisco, California. The platform caters to both professional traders and novices, offering features such as futures trading, leveraged tokens, and an over-the-counter portal. It supports a variety of financial products, including quarterly and perpetual futures for major cryptocurrencies like bitcoin, ether, and binance coin, as well as various altcoin and midcap indices. FTX was co-founded by Sam Bankman-Fried and Gary Wang, with initial backing from Alameda Research, which provided significant liquidity from the outset. The exchange aims to enhance the cryptocurrency trading experience and facilitate institutional adoption within the sector.

Innovusion

Series B in 2021
Innovusion, Inc. is a prominent developer of image grade LiDAR sensor systems, specifically designed for level 4 and 5 autonomous vehicles and advanced driver-assistance systems (ADAS). Founded in 2016 and based in Sunnyvale, California, Innovusion focuses on providing solutions that combine range, resolution, and hardware-accelerated sensor fusion within a compact and cost-effective framework. This unique approach makes their products suitable for the most demanding applications in the autonomous driving sector. As a venture-backed company, Innovusion is positioned at the forefront of innovation in the rapidly evolving automotive technology landscape.

Woebot Health

Series B in 2021
Woebot Health develops digital mental health solutions aimed at making mental health support widely accessible. Founded in 2017 and headquartered in San Francisco, the company utilizes chatbot technology to provide personalized support for mood-based disorders. Its platform integrates natural language processing with established therapeutic techniques, creating engaging interactions that deliver tailored responses to users facing specific mental health challenges. This innovative approach allows individuals to access effective mental health support conveniently, fitting seamlessly into their daily lives. Woebot Health is backed by several venture capital firms, emphasizing its commitment to advancing mental health care through technology.

FTX

Series B in 2021
FTX Trading LTD is a cryptocurrency derivatives exchange founded in 2017 and based in San Francisco, California. The platform caters to both professional traders and novices, offering features such as futures trading, leveraged tokens, and an over-the-counter portal. It supports a variety of financial products, including quarterly and perpetual futures for major cryptocurrencies like bitcoin, ether, and binance coin, as well as various altcoin and midcap indices. FTX was co-founded by Sam Bankman-Fried and Gary Wang, with initial backing from Alameda Research, which provided significant liquidity from the outset. The exchange aims to enhance the cryptocurrency trading experience and facilitate institutional adoption within the sector.

Fortera

Series B in 2021
Fortera develops a process for recreating the natural material that provides significant economic savings. It Founded in 2017 and is based in Campbell, California.

Umoja Biopharma

Series B in 2021
Provider of immunotherapies intended to transform cancer treatment and improve quality of life. The company's cellular immunotherapy platform uses gene therapy to target cancer cells and delivers to any patient, with any tumor, at any time to directly, safely, and controllably attack cancer, enabling medical practitioners to safeguard patients by creating and harnessing a powerful immune response in the body.

Einride

Series B in 2021
Einride AB is a freight mobility company that specializes in the transportation of goods using innovative technologies. Founded in 2016 and headquartered in Stockholm, Sweden, with additional offices in Gothenburg and Palo Alto, Einride focuses on developing electric and autonomous logistics solutions. The company's flagship products include Einride Pods, which are electric trucks designed for transporting a variety of cargo, including pallets, timber, and perishable goods. Einride also provides clients with tools to plan, order, and track sustainable transport, aiming to redefine logistics through intelligent freight mobility solutions.

Innovusion

Series B in 2021
Innovusion, Inc. is a prominent developer of image grade LiDAR sensor systems, specifically designed for level 4 and 5 autonomous vehicles and advanced driver-assistance systems (ADAS). Founded in 2016 and based in Sunnyvale, California, Innovusion focuses on providing solutions that combine range, resolution, and hardware-accelerated sensor fusion within a compact and cost-effective framework. This unique approach makes their products suitable for the most demanding applications in the autonomous driving sector. As a venture-backed company, Innovusion is positioned at the forefront of innovation in the rapidly evolving automotive technology landscape.

Manner

Series B in 2021
Manner Coffee operates a specialty coffee chain across several cities in China, including Shenzhen, Beijing, Chengdu, and Suzhou. Founded in 2015 and headquartered in Shanghai, the company focuses on making quality coffee accessible and affordable to a broad audience. Manner offers a diverse menu that includes coffee, tea, smoothies, juices, and desserts. In addition to beverages, the company sells coffee machines and cups. Manner is committed to environmental sustainability, incentivizing customers to bring their own reusable cups by offering a discount for each instance. This initiative reflects the company's dedication to both providing excellent coffee and promoting ecological responsibility.

Pairwise

Series B in 2021
Pairwise is a food and technology company focused on enhancing the quality and appeal of fruits and vegetables through advanced gene-editing techniques. Founded in 2017 by a team of experts from diverse fields, Pairwise aims to create healthier and more convenient produce by developing new varieties of leafy greens, berries, and stone fruits. The company holds licenses for innovative gene-editing tools and is building an internal portfolio of traits designed to improve taste, texture, and nutritional value while also addressing environmental concerns. With a commitment to transforming dietary habits and reducing food waste, Pairwise collaborates with food and agriculture companies to deliver differentiated products that meet evolving consumer demands. The company is headquartered in San Diego, California.

Exegenesis Bio

Series B in 2021
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.

Locanabio

Series B in 2020
Locanabio, Inc. develops RNA-targeted gene therapies to treat a spectrum of underserved diseases. It offers therapies for neuromuscular, neurodegeneration, and ophthalmology diseases. Locanabio, Inc. was formerly known as Locana, Inc. and changed its name to Locanabio, Inc. in July 2020. The company was founded in 2016 and is based in San Diego, California.

v2food

Series B in 2020
v2food is a plant-based meat startup that produces legume-based meat alternatives. The company v2 product is a delicious, nutritious alternative for anyone who loves the taste of meat but doesn’t want to get it from animals. It is a safe space to connect with like-minded people and create positive relationships with food that will help them feed the planet in a sustainable way. v2food was founded by Nick Hazell in 2019 and is based in Sydney, New South Wales, Australia.

Nuvia

Series B in 2020
Nuvia develops processors intended to create high-performance silicon design for a compute-intensive world. It designs processing chipsets for data center servers, thereby delivering a faster, power-efficient, and secure experience to existing data center processors. Manu Gulati, John Bruno, and Gerard Williams III launched Nuvia in Santa Clara, California in 2019.

Lu Daopei Medical Group

Series B in 2020
Lu Daopei Medical Group is a prominent healthcare provider based in Beijing, China, specializing in hematology and bone marrow transplantation. Founded in 2002, the group operates a network of hospitals that offer a range of services, including departments focused on bone marrow transplantation, general hematology, lymphoma and myeloma treatment, as well as pathology and specialty hematology laboratories. The organization is recognized for its expertise in stem cell transplantation and oncology, providing comprehensive clinical diagnosis and treatment options. Lu Daopei Medical Group aims to assist patients in navigating the complexities of their medical care, ultimately reducing their anxiety and improving treatment outcomes.

Glympse Bio

Series B in 2020
Glympse Bio, Inc. is focused on developing innovative diagnostic solutions that facilitate noninvasive monitoring of various diseases, including cancer, fibrosis, immunological disorders, and infectious diseases. The company employs modular nanoparticle sensors, utilizing precisely engineered diagnostic agents that assess disease states within the body and convey this information through urine analysis. This approach allows for predictive monitoring and evaluation of treatment responses. Founded in 2015 and based in Cambridge, Massachusetts, Glympse Bio's technology is rooted in research originally conducted at MIT and led by a team of experts in nanomedicine and biomedical engineering. Their flagship product, Glympse Inside, serves as a comprehensive platform for disease monitoring and aims to revolutionize how diseases are diagnosed and managed.

JW Therapeutics

Series B in 2020
JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, focuses on developing, manufacturing, and commercializing cell-based immunotherapies for hematological cancers and solid tumors. The company offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is relmacabtagene autoleucel, an anti-CD19 CAR-T therapy for relapsed or refractory B-cell lymphoma. JW (Cayman) Therapeutics Co. Ltd was founded in 2016 and is headquartered in Shanghai, China.

Tropic Biosciences

Series B in 2020
Tropic Biosciences UK LTD is a biotechnology company focused on developing high-performing commercial varieties of tropical crops, specifically targeting the coffee and banana industries. Established in 2016 and headquartered in Norwich, United Kingdom, the company employs advanced non-GMO gene editing technologies to enhance crop performance while promoting grower wellbeing and consumer health. Through its innovative approach, Tropic Biosciences aims to improve sustainable agricultural practices and address the challenges faced by tropical crop producers.

Genor BioPharma

Series B in 2020
Genor BioPharma Co., Ltd. is a biopharmaceutical company based in Shanghai, China, established in 2007. The company specializes in the development and commercialization of therapeutic monoclonal antibodies (mAbs) and Fc-fusion protein drugs, focusing on oncology, autoimmune diseases, and metabolic conditions. Genor BioPharma is actively advancing a diverse pipeline of over ten products, with ten candidates currently in clinical development. Its key drug candidates include GB491, an oral CDK4/6 inhibitor, GB221, a novel HER2 mAb, and geptanolimab, among others. The company aims to address significant unmet medical needs in its therapeutic areas. Genor has also formed a strategic collaboration with Ascentage Pharma to enhance its research and development capabilities.

Ascus Biosciences

Series B in 2020
Ascus Biosciences, founded in 2015 and headquartered in San Diego, California, focuses on developing a computational and genomics-based technology platform aimed at discovering and creating next-generation microbial products. The company's innovative approach leverages advanced data analysis and genomic insights to enhance the development of microbial solutions, catering to various applications in biotechnology and related fields.

ShopBack

Series B in 2020
ShopBack offers a one-stop lifestyle portal that powers smarter purchase decisions for consumers. Today, ShopBack is the dominant player in Southeast Asia’s e-commerce Cashback market, with an established presence in Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, powering over 1,000 orders per hour. ShopBack enhances shopping by providing up to 30% Cashback for consumers to boost their purchasing power while providing cost-effective marketing solutions for merchant partners. With over 1,300 merchant partners, including Uber, Expedia, and Lazada, ShopBack constantly strives to bring a smarter shopping experience to the consumers. In October 2015, ShopBack was awarded the winner of the Gold award in the Best Start-up (Growth Stage) category and Silver award in the Best Innovative Infocomm Products (Consumers) category at the 7th Singapore Infocomm Technology Federation (SiTF) Awards. This is the local start-up’s maiden voyage in industry awards, pitting against more than 300 nominations for the esteemed titles. The company was recently awarded the Emerging Enterprise Award in September 2016, jointly organized by The Business Times (Singapore) and OCBC Bank, which recognizes outstanding small and medium enterprises (SMEs) in Singapore.

Fabric

Series B in 2020
Fabric is developing an on-demand supply chain solution aimed at grocery retailers, enabling them to provide sustainable, one-hour delivery services to their online customers. The company has created Micro-Fulfillment Centers, which are urban, automated fulfillment facilities designed to optimize local distribution while maintaining cost-efficiency. By leveraging advanced robotics and artificial intelligence, Fabric redefines the fulfillment and delivery process in urban settings. This innovative approach addresses the challenges of last-mile delivery, allowing retailers to implement true on-demand services, significantly lower operational costs, and achieve enhanced scalability in their operations.

UPSIDE Foods

Series B in 2020
UPSIDE Foods, formerly known as Memphis Meats, is a company headquartered in San Francisco, California, that specializes in producing cultured meat directly from animal cells. Founded in 2015 by Uma Valeti and Nicholas Genovese, the company focuses on developing products such as hot dogs, sausages, burgers, and meatballs without the need to raise and slaughter animals. This innovative approach to meat production requires significantly less caloric input, water, land, and energy compared to traditional methods, while also aiming to provide consumers with cleaner meat products that are free from harmful chemicals.

Soul Machines

Series B in 2020
Soul Machines Limited specializes in creating emotionally responsive avatars that enhance user interactions with artificial intelligence platforms. Founded in 2016 and headquartered in Auckland, New Zealand, the company also operates offices in major cities including San Francisco, New York, London, Tokyo, and Melbourne. Its flagship product, Digital DNA Studio, empowers users to design custom digital personas for various applications, including customer care, marketing, education, and training. By leveraging advanced technology, Soul Machines aims to redefine customer engagement and promote deeper interactivity, ultimately transforming how individuals interact with machines and brands. The company's innovative approach focuses on creating empathetic AI assistants that facilitate meaningful human-machine collaboration, enhancing overall user experiences across multiple sectors, from retail to healthcare.

Transcenta

Series B in 2020
Transcenta Holding Ltd. is a clinical-stage biotherapeutics company specializing in the research, development, and manufacturing of antibody-based therapeutics. Founded in 2019 and headquartered in Suzhou, China, Transcenta has additional facilities in major cities including Shanghai, Hangzhou, and Beijing, as well as in Waltham, Massachusetts, and Princeton, New Jersey. The company was formed through the merger of HJB and MabSpace Biosciences and focuses on developing innovative antibodies aimed at treating various conditions. Currently, Transcenta is advancing nine therapeutic antibody molecules targeting oncology and select non-oncology indications, including bone and kidney disorders.

Eigen Technologies

Series B in 2019
Eigen Technologies Limited specializes in developing software for data extraction and mining, utilizing machine learning algorithms to analyze and interpret text. Founded in 2014 and headquartered in London, with an additional office in New York, the company automates the extraction and classification of information from various types of documents, enabling clients in finance, law, and professional services to make informed decisions. By employing advanced natural language processing technology, Eigen recognizes patterns within text to provide accurate answers to specific queries and classify documents based on relevant attributes. This capability allows clients to meet regulatory requirements, assess risks, and make strategic decisions regarding asset portfolios. Eigen's solutions can be deployed on-premises or in cloud environments, integrating seamlessly into existing workflows and transforming unstructured qualitative data into actionable insights.

pureLiFi

Series B in 2019
pureLiFi Ltd. is a technology company based in Edinburgh, UK, specializing in light communication solutions through its innovative Li-Fi technology. This technology utilizes visible light spectrum instead of traditional radio frequencies for wireless data communication, addressing the growing demand for bandwidth. The company's product offerings include Li-1st for developing VLC applications, Li-Flame for secure wireless networking, and the Li-Fire Platform for enhanced communication using visible light. Additionally, pureLiFi provides devices like LiFi-XC, which includes access points and USB dongles, ensuring compatibility with various operating systems. The applications of pureLiFi's technology span several sectors, including healthcare, aviation, and transportation, enabling high-density data transfer while minimizing external network interference. Founded in 2012, pureLiFi was previously known as pureVLC Ltd. before rebranding in 2013.

Bowery

Series B in 2019
Bowery Farming Inc. is a modern agricultural company based in New York City, specializing in the cultivation of post-organic produce such as baby kale, lettuce, arugula, and basil. Founded in 2014, Bowery employs advanced technology, including its proprietary BoweryOS software, to create optimal growing conditions in indoor farms. This system utilizes automation, machine learning, and vision systems to monitor plant growth continuously, resulting in highly efficient farming practices. Bowery's operations use zero pesticides and consume 95% less water while achieving over 100 times the productivity of traditional farming methods on the same land area. The company sells its products through grocery stores, including select Whole Foods and Foragers locations, and supplies produce to various restaurants, including those owned by renowned chef Tom Colicchio. Bowery Farming is committed to transforming agriculture to ensure a sustainable and healthier food supply for the future.

Viela Bio

Series B in 2019
Viela Bio, Inc. is a clinical-stage biotechnology company based in Gaithersburg, Maryland, focused on developing treatments for severe inflammation and autoimmune diseases. Its lead product candidate, inebilizumab, is a humanized monoclonal antibody targeting CD19, aimed at treating conditions such as neuromyelitis optica spectrum disorder, kidney transplant desensitization, myasthenia gravis, and IgG4-related diseases. The company is also advancing additional candidates, including VIB4920 for kidney transplantation rejection and Sjögren’s syndrome, as well as VIB7734 for cutaneous lupus erythematosus. Viela Bio has formed a strategic collaboration with Mitsubishi Tanabe Pharma Corporation to develop and commercialize inebilizumab for autoimmune diseases across several countries in Asia. Founded in 2017, the company is dedicated to addressing unmet medical needs in the field of autoimmune disorders.

Gracell

Series B in 2019
Gracell Biotechnologies Inc. is a clinical-stage biopharmaceutical company based in Shanghai, China, focused on discovering and developing innovative cell therapies for cancer treatment. The company's lead product candidates include GC012F, a dual-targeted CAR-T therapy for multiple myeloma currently in Phase I trials; GC019F, which targets adult B cell acute lymphoblastic leukemia and is also in Phase I trials; and GC007F, aimed at B cell non-Hodgkin’s lymphoma, also in Phase I. Additionally, Gracell is developing GC027, a CAR-T candidate targeting adult T cell acute lymphoblastic leukemia, and GC007g, an allogeneic CAR-T therapy for relapsed or refractory B-ALL, both in Phase I trials. Beyond these, Gracell has a pipeline of earlier-stage product candidates targeting various cancers, including ovarian and breast cancer. Founded in 2017, Gracell Biotechnologies is committed to advancing cellular therapeutics to improve patient outcomes in hematological malignancies and solid tumors.

Perfect Day

Series B in 2019
Perfect Day, Inc. is a company that specializes in producing animal-free dairy products, including milk, cheese, yogurt, and ice creams. Founded in 2014 and headquartered in Emeryville, California, the company utilizes yeast fermentation of plant-based sugars to create dairy proteins that are nutritionally identical to those found in cow's milk. This innovative approach allows Perfect Day to offer products that replicate the taste, texture, and nutritional benefits of traditional dairy while avoiding the environmental and ethical concerns associated with animal agriculture. The company's offerings are sustainable, vegan, and free from antibiotics, cholesterol, and lactose, catering to consumers seeking healthier and more compassionate alternatives to conventional dairy.

Bowery

Series B in 2018
Bowery Farming Inc. is a modern agricultural company based in New York City, specializing in the cultivation of post-organic produce such as baby kale, lettuce, arugula, and basil. Founded in 2014, Bowery employs advanced technology, including its proprietary BoweryOS software, to create optimal growing conditions in indoor farms. This system utilizes automation, machine learning, and vision systems to monitor plant growth continuously, resulting in highly efficient farming practices. Bowery's operations use zero pesticides and consume 95% less water while achieving over 100 times the productivity of traditional farming methods on the same land area. The company sells its products through grocery stores, including select Whole Foods and Foragers locations, and supplies produce to various restaurants, including those owned by renowned chef Tom Colicchio. Bowery Farming is committed to transforming agriculture to ensure a sustainable and healthier food supply for the future.

Pivot Bio

Series B in 2018
Pivot Bio is a biotechnology company founded in 2010 and based in Emeryville, California, that focuses on enhancing crop nutrition through the use of engineered microbes. The company leverages its deep understanding of the plant microbiome, employing engineering principles and data science to map microbial dynamics and develop beneficial traits. Pivot Bio's proprietary ON Technology utilizes naturally occurring microbes to provide crops with essential nutrients, particularly nitrogen, which is crucial for growth. This innovative approach aims to replace synthetic nitrogen fertilizers, thereby reducing the environmental impact associated with conventional farming practices. By enhancing crops' ability to capture and metabolize atmospheric nitrogen, Pivot Bio seeks to lower farming costs, improve crop yields, and contribute to a sustainable agricultural future that benefits both the planet and food supply.

BITMAIN

Series B in 2018
Bitmain is a manufacturer of Bitcoin mining hardware and other related services. Bitmain was founded by several of the digital currency industry’s earliest players, and their team is comprised of passionate and pedigreed engineers, financial experts, and Bitcoin enthusiasts. Bitmain is headquartered in Beijing and has offices in San Francisco, Tel Aviv, Hong Kong, Chengdu and Shenzhen.

WeWork

Series B in 2018
WeWork, formerly known as The We Company, is a commercial real estate firm that specializes in providing flexible shared workspaces and office services primarily for entrepreneurs, startups, and small businesses. Founded in 2010 and headquartered in New York, the company transforms buildings into dynamic environments that foster creativity, collaboration, and productivity. Its offerings include a range of workplace solutions, such as private offices, shared workspaces, and on-demand access to workstations. Additionally, WeWork connects members with a variety of third-party services and resources to support their business needs. The company emphasizes inclusivity and community, aiming to create a vibrant network of professionals who can collaborate and innovate together. With locations in various global markets, including China, WeWork continues to adapt its services to meet the evolving demands of the modern workforce.

SHIELD

Series B in 2018
SHIELD is a company that specializes in fraud management solutions, helping enterprises mitigate risks associated with fraudulent payments and accounts. Utilizing advanced technology, including trading algorithms and real-time pattern recognition, SHIELD effectively identifies fraudulent behaviors without human intervention. The company provides a range of services, including payment fraud prevention, account takeover protection, and promotional fraud mitigation. With a global client base that includes major enterprises such as Razer and Alibaba, SHIELD safeguards over seven billion devices and 500 million user accounts annually, fostering trust and safety in the digital landscape. Founded in 2007 and based in Singapore, SHIELD continues to enhance its offerings in fraud prevention, network security, credit intelligence, and identity verification.

Claroty

Series B in 2018
Claroty Ltd. operates a cybersecurity platform focused on securing operational technology (OT) environments, such as industrial control systems and supervisory control and data acquisition (SCADA) networks. The company helps organizations enhance the safety, reliability, and efficiency of their automated production sites by bridging the gap between information technology (IT) and OT. Claroty’s solutions enable organizations to leverage their existing IT security processes to manage visibility, risk, and vulnerabilities without necessitating downtime or additional teams. Founded in 2014 and headquartered in New York City, Claroty has garnered significant investment and is recognized for its ability to provide actionable insights and anomaly detection within industrial networks. Its technology is deployed globally, supporting critical infrastructure operators and enterprises in mitigating security and financial risks while improving operational performance.
Hangzhou Just Biotherapeutics, Ltd., also known as Just China, is a biotechnology company founded in 2016 and located in Hangzhou, China. The company specializes in developing antibody and recombinant protein biotherapeutics, focusing on accelerating the development of biomedicines while significantly reducing manufacturing costs. It excels in molecular design, process design, drug product design, and the design of manufacturing facilities. Initially a subsidiary of Just Biotherapeutics, Inc., it became a subsidiary of MabSpace Biosciences Co., Ltd. in January 2019.

Helix

Series B in 2018
Helix is a prominent population genomics company that operates at the intersection of clinical care, research, and data analytics. The company provides an end-to-end platform designed to facilitate genomic research and the incorporation of genomic data into healthcare practices. Helix operates one of the largest CLIA/CAP-certified next-generation sequencing laboratories and utilizes its proprietary Exome+™ assay to support various aspects of population genomics. These include recruitment and engagement, clinically actionable disease screening, and the return of results. Additionally, Helix engages in large-scale genetic analysis and viral surveillance, delivering actionable genetic insights that aid health systems, life sciences companies, payers, and government entities in enhancing patient care and informing public health decisions.

Rokid

Series B in 2018
Rokid Corporation is an artificial intelligence and robotics company founded in 2014, with its headquarters in Hangzhou, China, and research centers in Beijing and San Francisco. The company specializes in developing smart home devices, including Pebble and Alien, which utilize advanced AI and deep learning to facilitate voice and visual interactions. Rokid's products offer various functionalities, such as access to weather updates, smart home automation, music, and basic chat, enhancing user experience through multi-dimensional interaction. The company's focus on speech recognition, natural language processing, and image recognition allows its devices to cater to specific consumer needs. Additionally, Rokid has received recognition for its innovation, winning CES innovation awards consecutively in 2016 and 2017. This commitment to superior industrial design and user experience positions Rokid as a leader in the fields of robotics and AI technology.

Pear Therapeutics

Series B in 2018
Pear Therapeutics, Inc. focuses on developing and delivering clinically validated software-based therapeutics aimed at treating behavioral health disorders, including psychiatric and neurologic conditions. The company creates digital therapies for severe conditions such as addiction, schizophrenia, pain, post-traumatic stress disorder, anxiety, depression, and chronic insomnia. Its key products include mobile digital therapies that incentivize patients for completing treatment modules, reSET for substance use disorder, reSET-O for opioid use disorder, and Somryst for insomnia. Additionally, Pear Therapeutics offers PearConnect, a comprehensive patient services center that provides support for patients throughout their treatment journey, connects healthcare providers to resources, and assists insurance companies with claims processing. Founded in 2013, Pear Therapeutics is headquartered in Boston, Massachusetts, with an additional office in San Francisco, California.

Orchard Therapeutics

Series B in 2017
Orchard Therapeutics is a biopharmaceutical company based in London, focused on developing innovative gene therapies for serious and life-threatening rare diseases. Operating in the United Kingdom, European Union, and the United States, Orchard employs an autologous ex vivo gene therapy approach to transform patients’ hematopoietic stem cells into gene-modified products for treatment through a single administration. Its portfolio includes Strimvelis, the first approved gene therapy for adenosine deaminase-severe combined immunodeficiency (ADA-SCID), along with several products in clinical development targeting metachromatic leukodystrophy, Wiskott-Aldrich syndrome, X-linked chronic granulomatous disease, and transfusion-dependent beta-thalassemia. The company also has a robust preclinical pipeline addressing various mucopolysaccharidosis types. Orchard collaborates with leading institutions in gene therapy, enhancing its research capabilities and clinical programs. Founded in 2015, Orchard Therapeutics continues to demonstrate a commitment to transforming the lives of patients through its advanced therapies.

Arterys

Series B in 2017
Arterys Inc. is a technology company specializing in medical imaging analytics, aiming to enhance patient care through innovative solutions. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a cloud-based, AI-powered platform that enables radiologists to visualize and quantify blood flow in the body. Its product lineup includes Cardio AI for cardiac imaging, Lung AI for lung analysis, Liver AI for liver diagnostics, and Chest/MSK AI for detecting various thoracic and musculoskeletal conditions. The platform is fully web-based and FDA-cleared, providing clinicians with tools for automatic and interactive reporting. Additionally, the Arterys PHI Service allows physicians to access patient data remotely, further supporting efficient medical practices.

Genuity Science

Series B in 2017
Genuity Science is a contract genomics and data-sourcing organization based in Boston, Massachusetts, with additional offices in Dublin, Ireland, and Reykjavik, Iceland. The company collaborates with global biopharma firms to provide comprehensive discovery services that enhance precision health and improve patient outcomes. Its offerings encompass population-scale, disease-specific data sourcing, high-quality sequencing, and advanced statistical analysis, along with software tools for managing large datasets and artificial intelligence applications. Genuity operates state-of-the-art CAP/CLIA genomics laboratories in Woburn, Massachusetts, and Dublin, emphasizing a strong commitment to data stewardship and governance. The company focuses on exploring biological data insights, storage, interpretation, and scalable analytics, particularly in the central nervous system, cardiometabolic, and inflammatory disease sectors.
Hangzhou Just Biotherapeutics, Ltd., also known as Just China, is a biotechnology company founded in 2016 and located in Hangzhou, China. The company specializes in developing antibody and recombinant protein biotherapeutics, focusing on accelerating the development of biomedicines while significantly reducing manufacturing costs. It excels in molecular design, process design, drug product design, and the design of manufacturing facilities. Initially a subsidiary of Just Biotherapeutics, Inc., it became a subsidiary of MabSpace Biosciences Co., Ltd. in January 2019.

Homology Medicines

Series B in 2017
Homology Medicines, Inc. is a genetic medicines company based in Bedford, Massachusetts, focused on improving the lives of patients with rare genetic diseases. The company employs a proprietary platform that utilizes human hematopoietic stem cell-derived adeno-associated virus vectors (AAVHSCs) to deliver genetic therapies in vivo, either through gene therapy or nuclease-free gene editing. This innovative approach allows for targeted treatment of various disease-relevant tissues, including the liver and central nervous system, through a single injection. Homology's lead product candidate, HMI-102, is currently in a Phase 1/2 clinical trial for treating phenylketonuria (PKU) in adults, while HMI-103 targets pediatric PKU patients, and HMI-202 is being developed for metachromatic leukodystrophy. Founded in 2015, Homology Medicines aims to address significant unmet medical needs by targeting the underlying causes of genetic disorders.

Within (VR/AR)

Series B in 2017
Within is the premier destination for innovative, entertaining, and informative story-based virtual reality and augmented reality. We bring together the best immersive experiences from the world's finest VR/AR creators—from gripping tales set in worlds of pure imagination to documentaries taking you further inside the news than ever before. Within supports all major headsets, including Oculus Quest, Rift, HTC Vive, Sony PlayStation VR, and Samsung Gear VR. To get started experiencing our ever-growing roster of content, just download our app for iPhone or Android today.

NextCODE Health

Series B in 2017
NextCODE Health LLC is a clinical diagnostics company specializing in sequence-based genomics. It offers a platform that assists healthcare professionals in obtaining clinical insights for rapid disease diagnosis. The company provides a range of services, including data analysis, genome interpretation, data mining, and sequencing services, both clinical and non-clinical. Founded on technology developed at deCODE genetics over 16 years, NextCODE focuses on integrating genome sequence data into patient care. Based in Cambridge, Massachusetts, the company was acquired by WuXi PharmaTech in 2015 and underwent a rebranding to Genuity Science in 2020. Through its innovative solutions, NextCODE aims to enhance the speed and accuracy of identifying genetic causes of diseases.

IguanaFix

Series B in 2016
IguanaFix operates an online marketplace that facilitates repair and maintenance services for residential and commercial properties. The platform allows users to post various tasks, such as plumbing, electrical work, and painting, while connecting them with qualified service providers. By conducting identity checks and scheduling on-demand visits, IguanaFix ensures a reliable experience for its customers. Users can compare prices and make payments at predetermined market rates, streamlining the process of finding and hiring technicians. To date, over 40,000 technicians have utilized the platform to complete more than one million jobs, reflecting its effectiveness in simplifying maintenance and field operations management.

Nio

Series B in 2016
Nio Limited is a prominent electric vehicle manufacturer based in Shanghai, China, focusing on the premium segment of the market. Founded in 2014, the company designs, jointly manufactures, and sells smart electric vehicles, including five, six, and seven-seater SUVs. Nio is recognized for its innovative technology, including battery swapping and autonomous driving features, which enhance user experience. Its model lineup includes the ES8, a high-performance seven-seater SUV launched in 2018, the ES6 five-seater SUV, and the EC6 electric coupe SUV. The company also provides a range of charging solutions, such as home charging, battery swapping services, and mobile charging options, alongside value-added services like insurance and maintenance. In addition to its electric vehicle offerings, Nio collaborates with organizations like Mobileye N.V. to advance its technology. As of 2023, Nio has sold over 160,000 electric vehicles, capturing approximately 2% of the new energy vehicle market in China.

pureLiFi

Series B in 2016
pureLiFi Ltd. is a technology company based in Edinburgh, UK, specializing in light communication solutions through its innovative Li-Fi technology. This technology utilizes visible light spectrum instead of traditional radio frequencies for wireless data communication, addressing the growing demand for bandwidth. The company's product offerings include Li-1st for developing VLC applications, Li-Flame for secure wireless networking, and the Li-Fire Platform for enhanced communication using visible light. Additionally, pureLiFi provides devices like LiFi-XC, which includes access points and USB dongles, ensuring compatibility with various operating systems. The applications of pureLiFi's technology span several sectors, including healthcare, aviation, and transportation, enabling high-density data transfer while minimizing external network interference. Founded in 2012, pureLiFi was previously known as pureVLC Ltd. before rebranding in 2013.

Modern Meadow

Series B in 2016
Modern Meadow, LLC is a biofabrication company established in 2011 and headquartered in Brooklyn, New York. The company specializes in producing animal-free leather and other cultured products, such as meat alternatives, through innovative methods that eliminate the need for animal slaughter. By utilizing living cells and fermentation-based processes, Modern Meadow develops lightweight materials that provide superior color, performance, and durability, while also promoting lab-to-brand traceability. Their approach significantly reduces the inputs of land, water, energy, and chemicals, contributing to lower greenhouse gas emissions. This focus on sustainability enables customers to maintain the quality and appearance of materials without relying on petrochemical inputs or animal-derived substances.

AccuraGen

Series B in 2016
AccuraGen Inc., founded in 2013 and located in Menlo Park, California, specializes in developing sequencing-based systems for detecting cancer mutations. The company has created a high-sensitivity technology that utilizes next-generation sequencing to identify cancer-related mutations in small amounts of circulating cell-free DNA (cfDNA) found in blood samples. This innovative approach addresses challenges in analyzing cfDNA by employing proprietary molecular biology techniques and computational algorithms that enhance error suppression. AccuraGen's system can amplify nanogram quantities of highly fragmented cfDNA over 1000-fold, allowing for the screening of a wide array of cancer-related genes with exceptional sensitivity, including at the single-digit molecular level. This technology aims to improve personalized cancer treatment by providing oncologists and clinicians with reliable molecular diagnostic capabilities.

Team8

Series B in 2016
Team8 is a venture capital firm founded in 2014 and based in Tel Aviv, Israel, with an additional office in New York City. The firm specializes in building and investing in early-stage startups, particularly in enterprise technology, cybersecurity, fintech, artificial intelligence, and data science. Team8 employs a unique Foundry model that not only identifies significant industry challenges but also ideates innovative solutions while supporting the growth of new companies. The firm collaborates closely with a network of C-level executives and industry leaders, leveraging their expertise to enhance startup success. Backed by prominent global corporations, Team8 aims to transform the landscape of technology and finance by co-founding companies that address the evolving needs of the marketplace.

Helix

Series B in 2015
HELIX, formerly Flux, was the first spin-out of Google X. Initially focused on generative building design to automate planning and design of sustainable buildings, HELIX pivoted in 2019 to attack the high cost and complexity of digitizing buildings. Based in Oakland, CA, HELIX built the HELIX Creator platform to enable architects, engineers, builders, and owner-operators to use LiDAR and photogrammetry to capture accurate building geometry and convert it into usable plans and models. HELIX users need accurate 2D and 3D information and access to documents and data related to the building without delays. HELIX is used to evaluate buildings' potential, plan for renovation, document buildings in detail for disaster planning and more. HELIX believes that for Digital Twins to achieve their potential the data must be accurate, intuitive to access and easy to keep up to date.

Jet

Series B in 2015
Jet operates a smart shopping platform that allows its member to shop online from various retailers. It enables users to shop products in various categories, such as household products, health and beauty, grocery, baby, pet supplies, electronics, home and furniture, appliances, patio and garden, toys and video games, books, music and movies, office products, automotive, sports and fitness, clothing, shoes and accessories, jewelry and watches, arts, and crafts and hobbies. Mark Lore, Mike Hanrahan, and Nate Faust founded Jet in April 2014, with its headquarters in Hoboken in New Jersey. Jet operates as a subsidiary of Wal-Mart Stores as of September 19, 2016.

Adyen

Series B in 2014
Adyen N.V. is a technology company based in Amsterdam, Netherlands, that operates a comprehensive payments platform designed to streamline the payment process for merchants. Founded in 2006, Adyen integrates various services including gateway, risk management, processing, acquiring, and settlement, allowing merchants to accept payments across multiple channels such as online, mobile, and in-store. The platform directly connects merchants to major payment networks like Visa and Mastercard, and offers valuable data insights to enhance transaction efficiency. With a presence in numerous countries including Brazil, Singapore, the United Kingdom, Canada, and the United States, Adyen supports a diverse range of merchants across different industries. The company has also expanded its capabilities by obtaining a banking license, facilitating better settlement of merchant accounts.

Visterra

Series B in 2014
Visterra, Inc. is a clinical-stage biopharmaceutical company focused on developing precision antibody-based treatments for difficult-to-treat diseases, particularly infectious diseases. Utilizing its Hierotope platform, Visterra designs monoclonal antibodies such as VIS410, aimed at treating hospitalized patients with influenza A, and VIS513 for Dengue fever. The company is also advancing VIS705, an antibody-drug conjugate for Pseudomonas aeruginosa infections, and VIS649, which targets Immunoglobulin A Nephropathy (IgAN). Founded in 2007 and based in Waltham, Massachusetts, Visterra was previously known as Parasol Therapeutics, Inc. The company operates as a subsidiary of Otsuka America, Inc. and emphasizes innovative therapeutic solutions to address significant unmet medical needs.

Krux

Series B in 2014
Krux Digital Inc. develops a cloud-based data management platform designed for marketers, media companies, publishers, and agencies on a global scale. The platform consolidates consumer data from various sources and devices, analyzes individual preferences, and activates this data in real time across multiple channels, including desktop, mobile, social, and video. Founded in 2010 and headquartered in San Francisco, Krux operates additional offices in major cities worldwide. The company provides a comprehensive range of services, including audience data management, identity management, and cross-channel frequency management. With its platform, Krux enables businesses to deliver tailored content, advertising, and shopping experiences, making it easier to engage audiences effectively. As of November 2016, Krux operates as a subsidiary of Salesforce.com.

ITutorGroup

Series B in 2014
ITutorGroup provides online education platforms for students and business professionals. Its products include VIPABC, TutorABC, VIPABCJr, and TutorABCJr for English-language learning, TutorMing for Mandarin Chinese language learning, and LiveH2H for live translations in multiple languages. Eric Yang, Jerry Huang, and Ming Yang founded ITutorGroup in 1998, with headquarters in Taipei City in Taiwan. It has additional offices in Shanghai in China and Santa Clara in California.

Xiaomi

Series B in 2011
Xiaomi Corporation is an internet company based in Beijing that specializes in the manufacture and distribution of smartphones, consumer electronics, and internet services. Founded in 2010, Xiaomi operates through several segments, including Smartphones, IoT and Lifestyle Products, Internet Services, and Others. The Smartphones segment focuses on selling a range of mobile devices, while the IoT and Lifestyle Products segment includes smart TVs, laptops, AI speakers, and various lifestyle items. The Internet Services segment offers advertising and value-added services, and the Others segment provides hardware repair services. Xiaomi aims to create a comprehensive user experience by integrating user feedback into product design and continuously innovating its offerings. It also engages in wholesale and retail activities, software and hardware development, and operates retail stores and service centers in multiple countries, including India, Russia, and various European nations. The company's commitment to providing high-quality products at competitive prices has fostered a loyal customer base both in China and internationally.

Secondmarket

Series B in 2010
SecondMarket operates an online platform that facilitates transactions involving private securities, catering to a variety of clients, including financial institutions, hedge funds, private equity firms, mutual funds, and high net worth individuals. The company provides a centralized marketplace and auction platform for illiquid assets, allowing private companies and investment funds to efficiently execute both primary and secondary transactions. As a registered broker-dealer and alternative trading system, SecondMarket adheres to regulatory standards set by FINRA, MSRB, SIPC, and the SEC. The platform aims to simplify the complexities associated with private securities and enhance accessibility for institutional and accredited investors.

9You

Series B in 2008
Nineyou is an interactive entertainment portal based in Shanghai, China, catering to Chinese language internet users globally. The platform offers a comprehensive range of online game services, including MMORPGs, casual games, and mobile games. In addition to gaming, Nineyou features fashionable digital entertainment content, chat and community services, and an Avatar System, enhancing user interaction and engagement. The company also provides wireless value-added services and other premium offerings, positioning itself as a multifaceted hub for digital entertainment and social interaction.

Inspired Capital

Series B in 2003
Inspired Capital plc specializes in providing a range of lending products tailored for small and medium enterprises (SMEs) in the United Kingdom. Their offerings include business cash advances, asset finance, trade finance, construction finance, recruitment finance, transport finance, enterprise finance guarantees, factoring, and invoice discounting. The company aims to simplify the borrowing process, ensuring that SMEs can access the necessary funds quickly and with minimal hassle. Inspired Capital's products are designed to support various business needs, such as expanding operations, hiring staff, investing in equipment, or maintaining cash flow. Established in Bristol, the company was previously known as Renovo Group plc before rebranding in August 2014 and has since transitioned to a private entity as of August 2015.

ShipServ

Series B in 2000
ShipServ helps buyers and suppliers of shipping supplies and services find each other faster and do business more efficiently. Our products and services bring the global community together online, in print, on ship and in person. We’re maritime industry innovators with the industry’s largest online trading platform, the most used supplier search engine, the leading ordering guide and the world’s first online maritime ad network. The high volumes of sourcing, trading and search data that our community shares every day helps us to deliver better results and more accurate information. No one facilitates the intelligent, trustworthy matching of suppliers and buyers better than ShipServ.

Exent

Series B in 2000
Exent Technologies Ltd. is a digital entertainment media company based in Petah Tikva, Israel, specializing in the marketing, merchandising, distribution, and monetization of mobile and PC games. The company operates GameTanium, a subscription service that grants access to a wide array of Android games on various devices including smartphones, tablets, and televisions. Additionally, Exent runs FreeRide Games, a platform offering over 400 premium, full-version PC casual games at no cost to users, supported by ads. Exent delivers games on demand for mobile operators, telecommunications providers, device manufacturers, and web portals, partnering with major industry players to enhance their services. With a portfolio of more than 2,500 games from over 150 publishers, Exent’s offerings are designed to boost user engagement and revenue for its partners. The company has garnered investments from notable firms, including Intel Capital and Cisco. Founded in 1992, Exent continues to innovate in the gaming space, providing both subscription-based and free gaming experiences to millions of players worldwide.

Savi Technology

Series B in 2000
Savi Technology, Inc. specializes in software solutions designed to enhance the tracking and management of cargo throughout the supply chain. The company offers a range of products, including Savi Insight for predictive and prescriptive analytics, Savi Visibility for real-time operational decision-making, Savi Locate for GPS tracking, and Savi IoT, which integrates RFID technology for efficient data capture and asset management. Founded in 1989 and based in Alexandria, Virginia, Savi serves a diverse clientele, including shippers, government agencies, logistics providers, and technology firms. The company's innovative applications leverage big data analytics and machine learning to improve in-transit visibility, reduce disruptions, enhance delivery performance, and lower logistics costs for over 1,000 organizations worldwide.

Terawave Communications

Series B in 2000
Terawave Communications, Inc. is a manufacturer of converged access and multi-service networking solutions, specializing in multi-service aggregation and passive optical network (PON) products. These offerings facilitate the convergence of data, voice, video, and circuit services, catering to a diverse clientele that includes service providers, government agencies, and enterprise customers across the globe, including the United States, Europe, Asia, Africa, and Latin America. Founded in 1998 and headquartered in Hayward, California, Terawave also maintains additional offices in Canada, Asia, and Europe, enhancing its operational reach. The company is a subsidiary of Occam Networks Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.